3Rottiers V, Najafi-Shoushtari S H, Kristo F, et al. MicroRNAs in metabolism and metabolic diseases[J]. Cold Spring Harb Syrup Quant Biol,2011,76(1) :225-233.
5Ramirez C M, Davalos A, Goedeke L, et al. MicroRNA 758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1[J]. Arterioscler Thromb Vasc Biol, 2011,31 (11) ~ 2707-2714.
6Song K H, Li T, Owsley E, etal. A putative role of mieroRNA in regulation of cholesterol 7 alpha-hydroxylase expression in human hepatocytes[J]. J Lipid Res,2010,51(8) :2223-2233.
7Viekers K C, Shoucri B M, Levin M G, etal. MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia[J]. Hepatology,2013,57(2) :533-542.
8Weber C, Schober A, Zerneck A. MicroRNAs in arterialremodelling, inflammation and atherosclerosis[J]. Curr Drug Targets, 2010,11 (8) : 950-956.
9Ni C W, Qiu H, Jo H. MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells[J]. Am J Physiol Heart Circ Physiol,2011,300 (5) ~ H1762-1769.
10Huang R S, Hu G Q, Lin B, et al. MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages [J]. J Investig Med,2010,58(8):961-967.
6Iwaguro H, Asahara T. Endothelial progenitor cell culture and gene transfer[J]. Methods Mol Med, 2005,112 : 239-247.
7Ingram D A, Cap lice N M, Mervin C, et al. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells[J]. Blood,2005,106(5) : 1525-1531.
8Fox A, Smythe J, Fisher N, et al. Mobilization of endotheiial progenitor cells into the circulation in burned patients[J]. Br J Surg, 2008,95 (2) : 244-251.
9Ho J W, Pang R W, Lau C, et al. Significance of circulating endothelial progenitor cells in hepatocellular carcinoma [J].Hepatology, 2006,44 (4) : 836-843.
10Christoph Kalka, Hassan Tehrani, Bernd Laudenberg, et al. VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease[J]. Ann Thorac Surg, 2000,70 (3) : 829-834.
2Winchester R, Wiesendanger M, O'Brien W, et al. Circulating activated and effector memory T cells are associated with calcification and clonal expansions in bicuspid and tricuspid valves of calcific aortic stenosisl-J]. J Immunol, 2011,187 (2) : 1006-1014.
3Avci A, Elnur A, Goksel A, et al. The relationship between neutrophil/lymphocyte ratio and caleific aortic stenosis E J]. Echocardiography,2014,31 (9) : 1031-1035.
4Nadlonek N, Lee JH, Reece TB, et al. Interleukin-1 beta induces an inflammatory phenotype in human aortic valve interstitial cells through nuclear factor kappa beta E J]. Ann Thorac Surg,2013,96(1) :155-162.
5Latif N, Sarathchandra P, Chester AH, et al. Expression of smooth muscle cell markers and co-activators in calcified aortic valvesEJ]. Eur Heart J,2014,12(1):e1-11.
6Bertazzo S, Gentleman E, Cloyd KL, et al. Nano-analytical electron microscopy reveals fundamental insights into human cardiovascular tissue calcificationeJ]. Nat Mater, 2013,12 (6) : 576-583.
7Venardos N, Nadlonek NA, Zhan Q, et al. Aortic valve calcification is mediated by a differential response of aortic valve interstitial cells to inflammation[J]. J Surg Res, 2014, 190 (1) : 1-8.
8Derwall M, Malhotra R, Lai CS, et al. Inhibition of bone morphogenetic protein signaling reduces vascular calcificationand atherosclerosis[J]. Arterioscler Thromb Vasc Biol,2012,32 (3) :613-622.
9Park JY, Ryu SK, Choi JW, etal. Association of inflammation, myocardial fibrosis and cardiac remodelling in patients with mild aortic stenosis as assessed by biomarkers and eehocardiography I-J]. Clin Exp Pharmacol Physiol,2014,41(3), 185-191.
10Kruger R, Rasmussen LM, Argraves WS, et al. Extracellular matrix biomarker, fibulin-1, is closely related to NT-proBNP and soluble urokinase plasminogen activator receptor in patients with aortic valve stenosis (the SEAS study) I-J]. PLoS One, 2014,9(7) : e101522.
